Total trials
111
Active
24
Phase 3
5
Total enrollment
27,657
Pipeline matrix
Showing 9 of 9 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Finerenone | — | — | — | — | 2 | ||
| Semaglutide, 1.34 mg/mL | — | — | — | — | — | 2 | |
| Dapagliflozin | — | — | — | — | 2 | ||
| Low-Dose Glucagon | — | — | — | — | — | 1 | |
| Sotagliflozin | — | — | — | — | 2 | ||
| Aspirin | — | — | — | — | — | 1 | |
| Semaglutide | — | — | — | — | — | 1 | |
| Novorapid | — | — | — | — | — | 1 | |
| Humalog | — | — | — | — | — | 1 |
Next readouts
- 2026-11-30
- 2026-12-31
- 2027-05
- 2027-05-01
- 2029-07-01
Top conditions
- Type 1 Diabetes22
- Diabetes Mellitus, Type 114
- Type 2 Diabetes12
- Diabetes Mellitus, Type 210
- Hypoglycemia10
- Diabetes5
- Albuminuria4
- Nephropathy4
Frequently asked questions about Steno Diabetes Center Copenhagen
- How many clinical trials does Steno Diabetes Center Copenhagen have on ClinicalTrials.gov?
- Steno Diabetes Center Copenhagen is listed as the lead sponsor on 111 clinical trials in ClinicalTrials.gov, 24 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Steno Diabetes Center Copenhagen's trials are in Phase 3?
- 5 of Steno Diabetes Center Copenhagen's trials are in Phase 3, spread across 9 active drug programs.
- What therapeutic areas does Steno Diabetes Center Copenhagen focus on?
- Steno Diabetes Center Copenhagen's most-studied conditions on ClinicalTrials.gov are Type 1 Diabetes, Diabetes Mellitus, Type 1, Type 2 Diabetes, Diabetes Mellitus, Type 2, Hypoglycemia.
- When are Steno Diabetes Center Copenhagen's next clinical trial readouts?
- Steno Diabetes Center Copenhagen has 5 upcoming primary-completion readouts tracked here; the soonest is “Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study”, expected around 2026-11-30.